Table 2.
Identification of potential risk factors for an incomplete exam by univariate analysis in all patients
| Pre-procedure factors | P value | Post-procedure factors | P value |
| Location | 0.0001 | AVM | 0.001 |
| Occult GIB | 0.042 | Blood | 0.016 |
| Overt GIB | 0.054 | Visible vessel | 0.013 |
| Abdominal pain | 0.608 | Lymphoid hyperplasia | 0.014 |
| Assessment of IBD | 0.142 | GAVE | 0.051 |
| History of FAP | 0.999 | Findings suggestive of CD | 0.007 |
| History of DA | 0.199 | Excess food | 0.006 |
| Nausea/vomiting | 0.879 | Phlebectasia | 0.011 |
| Diarrhea | 0.929 | Large gastric folds | 0.010 |
| Colon polyps | 0.999 | White villi | 0.01 |
| History of OVR | 1 | Edema | 0.415 |
| History of carcinoid tumors | 0.999 | Submucosal mass | 0.372 |
| History of PJS | 1 | Mucosal mass | 0.119 |
| History of VE | 1 | Erosions | 0.350 |
| Age | 0.113 | Ulcer | 0.308 |
| Gender | 0.232 | Duodenitis | 0.597 |
| Diverticulitis | 0.461 | ||
| Mucosal break | 0.078 | ||
| Esophagitis | 0.062 | ||
| Stricture | 0.399 | ||
| Reader | 0.982 | ||
| GTT | 0.0001 | ||
| SBTT | 0.001 |
GIB: Gastrointestinal bleed; IBD: Inflammatory bowel disease; FAP: Familial adenomatous polyposis; DA: Duodenal adenoma; OVR: Osler Veber Rendu; PJS: Peutz Jeghers syndrome; VE: Vascular ectasia; AVM: Arteriovenous malformation; GAVE: Gastric vascular ectasia; CD: Crohn’s disease; GTT: Gastric transit time; SBTT: Small bowel transit time.